Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for GADICKE ANSBERT
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-04
Sale
2022-01-06
4:12 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
245,469$42.58$10,452,3344,484,728
(Indirect)
View
2021-12-03
Sale
2021-12-07
6:33 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
83,390$33.73$2,812,4284,730,197
(Indirect)
View
2021-11-30
Sale
2021-12-02
6:53 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
139,773$34.47$4,817,4174,813,587
(Indirect)
View
2021-11-26
Sale
2021-11-30
4:49 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
38,566$35.18$1,356,8254,953,360
(Indirect)
View
2021-11-17
Sale
2021-11-24
6:38 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
129,617$36.61$4,744,6665,007,597
(Indirect)
View
2021-11-02
Purchase
2021-11-04
5:37 pm
Entrada Therapeutics Inc.TRDAMPM BioVentures 2014 L.P.
EVNIN LUKE
GADICKE ANSBERT
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
100,000$20$2,000,0004,425,784
(Indirect)
View
2021-10-15
Sale
2021-10-18
4:33 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
28,615$27.45$785,3845,137,214
(Indirect)
View
2021-10-12
Sale
2021-10-14
5:26 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
95,002$27.21$2,584,6065,165,829
(Indirect)
View
2021-10-07
Sale
2021-10-12
4:33 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
87,006$27.23$2,368,8005,260,831
(Indirect)
View
2021-10-01
Sale
2021-10-05
4:31 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
46,130$27.05$1,247,5905,347,837
(Indirect)
View
2021-09-28
Sale
2021-09-30
5:05 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
35,990$27$971,7305,393,967
(Indirect)
View
2021-09-23
Sale
2021-09-27
5:51 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
89,476$27.76$2,484,0945,429,957
(Indirect)
View
2021-09-21
Sale
2021-09-23
4:18 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
56,779$27.5$1,561,3945,519,433
(Indirect)
View
2021-09-16
Sale
2021-09-20
6:30 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
152,711$28.38$4,334,4525,576,212
(Indirect)
View
2021-09-16
Sale
2021-09-20
5:30 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
3,556$29.06$103,3377,892,819
(Indirect
Direct)
View
2021-09-14
Sale
2021-09-16
4:46 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
76,417$27.7$2,116,7335,728,923
(Indirect)
View
2021-09-14
Sale
2021-09-16
4:44 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
15,401$29.17$449,1747,896,375
(Indirect
Direct)
View
2021-09-09
Sale
2021-09-13
7:02 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
96,456$28.32$2,731,4605,805,340
(Indirect)
View
2021-09-09
Sale
2021-09-13
6:22 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
26,468$29.23$773,7207,911,776
(Indirect
Direct)
View
2021-09-07
Sale
2021-09-08
7:19 pm
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
71,232$29.03$2,067,7865,933,136
(Indirect)
View
2021-09-03
Sale
2021-09-08
6:17 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
55,364$29.2$1,616,7497,938,244
(Indirect
Direct)
View
2021-08-31
Sale
2021-09-02
5:25 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
27,669$29.5$816,3527,993,608
(Indirect
Direct)
View
2021-08-27
Sale
2021-08-31
4:48 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
50,489$29.24$1,476,1358,021,277
(Indirect
Direct)
View
2021-08-23
Sale
2021-08-25
7:41 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
120,592$29.29$3,531,8208,071,766
(Indirect
Direct)
View
2021-08-11
Sale
2021-08-12
4:54 pm
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
2,857$29.05$82,9968,192,298
(Indirect
Direct)
View
2021-07-09
Sale
2021-07-13
4:21 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
62,079$33.55$2,082,8683,882,485
(Indirect)
View
2021-06-28
Sale
2021-06-30
5:25 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
19,200$34.06$653,9253,944,564
(Indirect)
View
2021-06-24
Sale
2021-06-28
4:07 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
28,688$33.51$961,4573,963,764
(Indirect)
View
2021-06-21
Sale
2021-06-23
5:38 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
42,798$34.36$1,470,4413,992,452
(Indirect)
View
2021-06-17
Sale
2021-06-21
4:06 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
41,518$33.77$1,402,0024,035,250
(Indirect)
View
2021-06-14
Sale
2021-06-16
5:09 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
6,227$33.25$207,0664,076,768
(Indirect)
View
2021-06-08
Sale
2021-06-10
4:04 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
61,430$34.05$2,091,4574,082,995
(Indirect)
View
2021-06-03
Sale
2021-06-07
6:39 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
58,149$32.01$1,861,6124,144,425
(Indirect)
View
2021-05-28
Sale
2021-06-02
6:09 pm
Harpoon Therapeutics Inc.HARPGADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
57,494$20.63$1,186,1906,328,095
(Indirect)
View
2021-05-28
Sale
2021-06-02
5:39 pm
Repare Therapeutics Inc.RPTXGADICKE ANSBERT
10% Owner
38,098$32.47$1,237,0424,202,574
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-07-28
Option Award
2022-08-01
4:34 pm
N/A
N/A
Allovir Inc.ALVRGADICKE ANSBERT
Director
10% Owner
3,253,796$4.6116,704,963
(Indirect)
View
2022-06-22
Option Award
2022-06-23
6:22 pm
N/A
2032-06-21
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
16,475$016,475
(Direct)
View
2022-05-17
Option Award
2022-05-19
4:27 pm
N/A
2032-05-16
Allovir Inc.ALVRGADICKE ANSBERT
Director
10% Owner
27,500$027,500
(Direct)
View
2021-09-16
Option Award
2022-03-25
7:32 pm
N/A
2031-09-15
Cullinan Oncology Inc.CGEMGADICKE ANSBERT
Director
10% Owner
7,800$07,800
(Direct)
View
2021-11-17
Other
2021-11-24
6:38 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
15,671$05,007,597
(Indirect)
View
2021-11-02
Conversion
2021-11-04
5:37 pm
N/A
N/A
Entrada Therapeutics Inc.TRDAMPM BioVentures 2014 L.P.
EVNIN LUKE
GADICKE ANSBERT
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
35,626,700$04,425,784
(Indirect)
View
2021-10-28
Ownership
2021-10-28
8:45 pm
N/A
N/A
Entrada Therapeutics Inc.TRDAMPM BioVentures 2014 L.P.
EVNIN LUKE
GADICKE ANSBERT
MPM BioVentures 2014 (B) L.P.
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM BioVentures 2014 GP LLC
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
10% Owner
0$04,325,784
(Indirect)
View
2021-09-07
Other
2021-09-08
7:19 pm
N/A
N/A
iTeos Therapeutics Inc.ITOSGADICKE ANSBERT
UBS Oncology Impact Fund L.P.
BioImpact Capital LLC
Oncology Impact Fund (Cayman) Management L.P.
10% Owner
31,340$05,933,136
(Indirect)
View
Goto 0, 1, 2, Next